LIGAND PHARMACEUTICALS INCORPORATED Intangible Assets, Net (Including Goodwill)
LIGAND PHARMACEUTICALS INCORPORATED (LGND) had Intangible Assets, Net (Including Goodwill) of $310.79 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Notes › Goodwill and Other
us-gaap:IntangibleAssetsNetIncludingGoodwill · last filed 2026-08-07
- 2026-06-30: Intangible Assets, Net (Including Goodwill) $310.79M.
- 2026-03-31: Intangible Assets, Net (Including Goodwill) $318.88M.
- 2025-12-31: Intangible Assets, Net (Including Goodwill) $326.98M.
- 2025-09-30: Intangible Assets, Net (Including Goodwill) $335.08M.
| Period end | Intangible Assets, Net (Including Goodwill) | Intangible Assets, Net (Including Goodwill) as first filed |
|---|---|---|
| 2026-06-30 | $310.79M 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $318.88M 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $326.98M 10-Q · filed 2026-08-07 | |
| 2025-09-30 | $335.08M 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $351.67M 10-Q · filed 2025-08-08 | |
| 2025-03-31 | $359.93M 10-Q · filed 2025-05-09 | |
| 2024-12-31 | $371.90M 10-K · filed 2026-02-27 | |
| 2024-09-30 | $380.15M 10-Q · filed 2024-11-08 | |
| 2024-06-30 | $388.41M 10-Q · filed 2024-08-07 | |
| 2024-03-31 | $396.67M 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $402.98M 10-K · filed 2025-02-28 | |
| 2023-09-30 | $418.61M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $431.05M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $439.59M 10-Q · filed 2023-05-08 | |
| 2022-12-31 | $448.13M 10-K · filed 2024-02-29 | |
| 2022-09-30 | $698.23M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $709.57M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $720.91M 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $482.36M 10-K · filed 2023-02-28 | $732.25M 10-K · filed 2022-02-28 |
| 2021-09-30 | $752.55M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $762.52M 10-Q · filed 2021-08-03 | |
| 2021-03-31 | $774.30M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $784.99M 10-K · filed 2022-02-28 | |
| 2020-09-30 | $326.72M 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $318.66M 10-Q · filed 2020-08-07 | |
| 2020-03-31 | $300.86M 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $305.68M 10-K · filed 2021-02-24 | |
| 2019-09-30 | $309.78M 10-Q · filed 2019-11-08 | |
| 2019-06-30 | $300.61M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $303.10M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $306.44M 10-K · filed 2020-02-27 | |
| 2018-09-30 | $302.24M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $307.96M 10-Q · filed 2018-08-08 | |
| 2018-03-31 | $311.27M 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $314.54M 10-K · filed 2019-02-28 | |
| 2017-09-30 | $268.79M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $271.49M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $274.20M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $276.91M 10-K · filed 2018-03-01 | |
| 2016-09-30 | $279.79M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $282.50M 10-Q · filed 2016-11-14 | |
| 2016-03-31 | $285.82M 10-Q · filed 2016-11-14 | |
| 2015-12-31 | $60.59M 10-K · filed 2017-02-28 | |
| 2015-09-30 | $61.18M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $61.77M 10-Q · filed 2015-08-05 | |
| 2015-03-31 | $62.37M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $62.96M 10-K · filed 2016-11-14 | $65.34M 10-K · filed 2014-12-01 |
| 2014-09-30 | $63.55M 10-Q · filed 2014-10-31 | |
| 2014-06-30 | $64.15M 10-Q · filed 2014-08-05 | |
| 2014-03-31 | $64.74M 10-Q · filed 2014-05-07 | |
| 2013-12-31 | $65.34M 10-K · filed 2015-02-23 | |
| 2013-09-30 | $65.93M 10-Q · filed 2013-11-08 | |
| 2013-06-30 | $66.48M 10-Q · filed 2013-08-01 | |
| 2013-03-31 | $67.56M 10-Q · filed 2013-05-08 | |
| 2012-12-31 | $68.15M 10-K/A · filed 2014-12-12 | |
| 2012-09-30 | $68.82M 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $69.40M 10-Q/A · filed 2012-11-14 | $71.17M 10-Q · filed 2012-08-08 |
| 2011-12-31 | $70.56M 10-K · filed 2013-03-14 | $72.33M 10-Q · filed 2012-08-08 |